NNVC CIK: 1379006

NanoViricides, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
millions USD
FY22:
14.4
FY23:
8.45
FY24:
4.97
FY25:
1.67
FY26:
3.16
(positive)
Change from FY22 to FY26
millions USD
FY22:
9.08
FY23:
8.45
FY24:
7.85
FY25:
7.15
FY26:
6.71
Total assets
Change from FY22 to FY26
millions USD
FY22:
23.5
FY23:
16.9
FY24:
12.8
FY25:
8.82
FY26:
9.87

Liabilities & Equity

(negative)
Change from FY22 to FY26
millions USD
FY22:
0.41
FY23:
0.53
FY24:
1.36
FY25:
1.31
FY26:
1.19
(negative)
millions USD
FY22:
0
FY23:
1.50
FY24:
0
FY25:
−0.01
FY26:
0.01
(positive)
Change from FY22 to FY26
millions USD
FY22:
23.1
FY23:
14.9
FY24:
11.5
FY25:
7.52
FY26:
8.68
Total liabilities & equity
Change from FY22 to FY26
millions USD
FY22:
23.5
FY23:
16.9
FY24:
12.8
FY25:
8.82
FY26:
9.88

All amounts in millions USD Data sources:SEC EDGARTwelve Data